TY  - JOUR 
AU  - Romero, Octavio A.
AU  - Andrades Delgado, Álvaro
AU  - Medina Vico, Pedro Pablo
PY  - 2021
UR  - http://hdl.handle.net/10481/70309
AB  - Despite the genetic inactivation of SMARCA4, a core component of the SWI/SNF-complex
commonly found in cancer, there are no therapies that effectively target SMARCA4-deficient
tumours. Here, we show that, unlike the cells with activated MYC...
LA  - eng
PB  - Nature
TI  - SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
DO  - 10.1038/s41467-021-24618-3
ER  -